Fulgent Genetics Expands Reach with Two Big Buys

Fulgent Genetics is making a big move in the lab world. They're buying two companies, Bako Diagnostics and StrataDx, for a cool $55. 5 million. This deal is expected to close in the first half of 2026, but only if all the necessary approvals come through. Fulgent is known for its tech-based approac